GE HEALTHCARE TECH.INC. (L0T) - Net Assets
Based on the latest financial reports, GE HEALTHCARE TECH.INC. (L0T) has net assets worth €10.90 Billion EUR (≈ $12.74 Billion USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€37.12 Billion ≈ $43.40 Billion USD) and total liabilities (€26.23 Billion ≈ $30.66 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Explore GE HEALTHCARE TECH.INC. (L0T) cash flow conversion to assess how effectively this company generates cash.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €10.90 Billion |
| % of Total Assets | 29.35% |
| Annual Growth Rate | 3.38% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 20.91 |
GE HEALTHCARE TECH.INC. - Net Assets Trend (2022–2025)
This chart illustrates how GE HEALTHCARE TECH.INC.'s net assets have evolved over time, based on quarterly financial data. Explore GE HEALTHCARE TECH.INC. (L0T) long-term investment share to see how much of total assets are deployed in long-term investments.
Annual Net Assets for GE HEALTHCARE TECH.INC. (2022–2025)
The table below shows the annual net assets of GE HEALTHCARE TECH.INC. from 2022 to 2025. For live valuation and market cap data, see GE HEALTHCARE TECH.INC. (L0T) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €10.60 Billion ≈ $12.39 Billion |
+22.50% |
| 2024-12-31 | €8.65 Billion ≈ $10.12 Billion |
+18.36% |
| 2023-12-31 | €7.31 Billion ≈ $8.55 Billion |
-23.79% |
| 2022-12-31 | €9.59 Billion ≈ $11.21 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to GE HEALTHCARE TECH.INC.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 528100000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €5.28 Billion | 50.88% |
| Other Components | €5.10 Billion | 49.12% |
| Total Equity | €10.38 Billion | 100.00% |
GE HEALTHCARE TECH.INC. Competitors by Market Cap
The table below lists competitors of GE HEALTHCARE TECH.INC. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Qnity Electronics, Inc
NYSE:Q
|
$23.89 Billion |
|
Semiconductor Manufacturing International Corporation
F:MKN2
|
$23.90 Billion |
|
POP MART INT.GRP.DL-0001
F:735
|
$23.91 Billion |
|
Royalty Pharma Plc
NASDAQ:RPRX
|
$23.92 Billion |
|
Compagnie Generale des Etablissements Michelin SCA
PA:ML
|
$23.87 Billion |
|
Nan Ya Plastics Corp
TW:1303
|
$23.86 Billion |
|
Alfa Laval AB
ST:ALFA
|
$23.86 Billion |
|
Swiss Life Holding AG
SW:SLHN
|
$23.84 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in GE HEALTHCARE TECH.INC.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 8,446,000,000 to 10,379,000,000, a change of 1,933,000,000 (22.9%).
- Net income of 2,084,000,000 contributed positively to equity growth.
- Dividend payments of 64,000,000 reduced retained earnings.
- Share repurchases of 200,000,000 reduced equity.
- Other factors increased equity by 113,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €2.08 Billion | +20.08% |
| Dividends Paid | €64.00 Million | -0.62% |
| Share Repurchases | €200.00 Million | -1.93% |
| Other Changes | €113.00 Million | +1.09% |
| Total Change | €- | 22.89% |
Book Value vs Market Value Analysis
This analysis compares GE HEALTHCARE TECH.INC.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.40x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 2.65x to 2.40x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-12-31 | €20.61 | €54.66 | x |
| 2023-12-31 | €15.67 | €54.66 | x |
| 2024-12-31 | €18.48 | €54.66 | x |
| 2025-12-31 | €22.77 | €54.66 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently GE HEALTHCARE TECH.INC. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 20.08%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 10.10%
- • Asset Turnover: 0.56x
- • Equity Multiplier: 3.56x
- Recent ROE (20.08%) is below the historical average (21.53%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | 20.48% | 10.45% | 0.67x | 2.94x | €980.30 Million |
| 2023 | 21.98% | 8.02% | 0.60x | 4.55x | €854.70 Million |
| 2024 | 23.60% | 10.13% | 0.59x | 3.92x | €1.15 Billion |
| 2025 | 20.08% | 10.10% | 0.56x | 3.56x | €1.05 Billion |
Industry Comparison
This section compares GE HEALTHCARE TECH.INC.'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $37,411,546,005
- Average return on equity (ROE) among peers: -877.09%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| GE HEALTHCARE TECH.INC. (L0T) | €10.90 Billion | 20.48% | 2.41x | $23.88 Billion |
| LEPU MED.T.B. SP.GDR O.N. (07Z0) | $17.50 Billion | 7.19% | 0.43x | $146.67K |
| BIORETEC OY (0TN) | $9.74 Million | -47.38% | 0.18x | $16.10 Million |
| SYSMEX CORP.UNSP.ADR 1/2 (0YX0) | $349.05 Billion | 12.63% | 0.39x | $4.70 Billion |
| INMODE LTD IS -01 (154) | $703.81 Million | 25.76% | 0.12x | $711.77 Million |
| HeraMED Limited (1I4) | $76.93K | -8590.94% | 35.29x | $28.30 Million |
| Medtronic PLC (2M6) | $1.75 Billion | 30.35% | 0.38x | $83.04 Billion |
| Peijia Medical Limited (4WO) | $2.64 Billion | -15.46% | 0.26x | $391.36 Million |
| AVITA Medical Inc (51KB) | $20.86 Million | -118.03% | 0.23x | $172.49 Million |
| BRAINCOOL AB (5YL) | $111.74 Million | -54.84% | 0.19x | $21.56 Million |
| MICROPORT CARDIO.MEDTECH. (72X) | $2.33 Billion | -20.20% | 0.10x | $107.57 Million |
About GE HEALTHCARE TECH.INC.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical… Read more